BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ImmunoCellular Therapeutics, Ltd 



Los Angeles  California    U.S.A.
Phone: Fax:


SEARCH JOBS




Industry
Biotechnology






 Company News
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Issuance Of Key Patent For ICT-107 Cancer Vaccine 12/17/2014 8:01:31 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback From European Medicines Agency On Advancing ICT-107 To Phase 3 Program 12/1/2014 8:51:15 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Presents Updated ICT-107 Phase 2 Data at the Society for Neuro-Oncology Annual Meeting 2014 11/14/2014 7:23:31 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Third Quarter 2014 Financial Results 11/10/2014 8:02:40 AM
ImmunoCellular Therapeutics, Ltd (IMUC) To Present At Livingston Securities Conference On October 1, 2014 9/26/2014 10:12:25 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Expands Cancer Immunotherapy Platform With Antigen-Specific T-Cell Technology Licensed From California Institute of Technology 9/24/2014 7:43:45 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback On ICT-107 Supporting Advancement To Registrational Phase 3 Testing In Newly Diagnosed Glioblastoma 9/17/2014 8:21:27 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Second Quarter 2014 Financial Results 8/8/2014 8:07:10 AM
ImmunoCellular Therapeutics, Ltd (IMUC) To Report Financial Results For The Second Quarter 2014 On August 7, 2014 7/30/2014 8:45:36 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Presents Updated ICT-107 Phase II Data In Patients With Newly Diagnosed Glioblastoma At The 2014 American Society of Clinical Oncology Annual Meeting 6/2/2014 6:44:44 AM
12345678910...